Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)

Journal of Diabetes Investigation

Volumn 3, Issue 6, 2012, Pages 536-539

  Imagawa, Akihisa ^a   Hanafusa, Toshiaki ^b   Awata, Takuya ^c   Ikegami, Hiroshi ^d   Uchigata, Yasuko ^e   Osawa, Haruhiko ^f   Kawasaki, Eiji ^g   Kawabata, Yumiko ^d   Kobayashi, Tetsuro ^h   Shimada, Akira ⁱ   Shimizu, Ikki ^j   Takahashi, Kazuma ^k   Nagata, Masao ^l   Makino, Hideichi ^m   Maruyama, Taro ⁿ  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^h UNIVERSITY OF YAMANASHI   (Japan)

ⁱ SAISEIKAI CENTRAL HOSPITAL   (Japan)

^j THE SAKAKIBARA HEART INSTITUTE OF OKAYAMA   (Japan)

^k IWATE MEDICAL UNIVERSITY   (Japan)

^l Kakogawa Municipal Hospital   (Japan)

^m Diabetes Center   (Japan)

ⁿ Saitama Social Insurance Hospital   (Japan)

more..

Author keywords

Criteria; Diagnosis; Fulminant

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; DIAGNOSTIC VALUE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MEDICAL SOCIETY; ONSET AGE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 84871645658     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12024     Document Type: Article

References (20)

1. Imagawa A, Hanafusa T, Awata T, et al. Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New Diagnostic Criteria of Fulminant Type 1 Diabetes Mellitus. J Jpn Diabetes Soc 2012; 55: 815-820 (Japanese).
2. Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000; 342: 301-307.
3. Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 2003; 26: 2345-2352.
4. Hanafusa T, Imagawa A, Iwahashi H, et al. Report of Japan Diabetes Society Committee on fulminant type 1 diabetes mellitus research: epidemiological and clinical analysis and proposal of diagnostic criteria. J Jpn Diabetes Soc 2005; 48(Suppl. 1): A1-A13 (Japanese).
5. Imagawa A, Hanafusa T, Uchigata Y, et al. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 2005; 48: 294-300. Erratum in: Diabetologia 2008; 51: 524-526.
6. Shimizu I, Makino H, Hanafusa T, et al. Immunogenetic charactristics of fulminant type 1 diabetes mellitus associated with pregnancy: a nationwide survey. J Jpn Diabetes Soc 2005; 48(Suppl. 1): A15-A19 (Japanese).
7. Shimizu I, Makino H, Imagawa A, et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab 2006; 91: 471-476.
8. Shimizu I, Makino H, Imagawa A, et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy: Report of the Japan Diabetes Society Committee on Fulminant Type 1 Diabetes Mellitus Research. J Jpn Diabetes Soc 2006; 49: 755-760 (Japanese).
9. Kawasaki E, Shimizu I, Hanafusa T, et al. Nationwide survey on the prevalence of type 1 diabetes associated with pregnancy. Diabetes Pregnancy 2006; 6: 104-107 (Japanese).
10. Hanafusa T, Imagawa A, Iwahashi H, et al. Report of the committee of the Japan Diabetes Society on research on fulminant type 1 diabetes mellitus: analysis of HLA serotype and diabetic microangiopathy. J Jpn Diabetes Soc 2007; 50: 825-833 (Japanese).
11. Hanafusa T, Imagawa A, Iwahashi H, et al. Report of the Japan Diabetes Society's Committee on fulminant type 1 diabetes mellitus: analysis of antiviral antibodies at disease onset. J Jpn Diabetes Soc 2008; 51: 531-536 (Japanese).
12. Imagawa A, Hanafusa T, Iwahashi H, et al. Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes. Diabetes Res Clin Pract 2008; 82: 233-237.
13. Takaike H, Uchigata Y, Iwamoto Y, et al. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus. Ann Med 2008; 40: 395-400.
14. Kawabata Y, Ikegami H, Awata T, et al. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 2009; 52: 2513-2521.
15. Koga M, Murai J, Saito H, et al. Serum glycated albumin to haemoglobin A(1C) ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus. Ann Clin Biochem 2010; 47: 313-317.
16. Nakamura K, Kawasaki E, Imagawa A, et al. Type 1 diabetes and interferon therapy: a nationwide survey in Japan. Diabetes Care 2011; 34: 2084-2089.
17. Tsutsumi C, Imagawa A, Ikegami H, et al. On behalf of the Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. Class II HLA genotype in fulminant type 1 diabetes - a nationwide survey with reference to glutamic acid decarboxylase antibodies. J Diabetes Invest 2012; 3: 62-69.
18. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 2012; 3: 8-10.
19. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012; 3: 39-40.
20. Hirata H, Shimada A, Imagawa A, et al. Clinical characteristics of cases that progress rapidly from type 2 diabetes to insulin deficiency like fulminant type 1 diabetes: subcommittee report on Fulminant and Acute Type 1 diabetes, Committee on Type 1 diabetes, Japan Diabetes Society. J Jpn Diabetes Soc 2012; 55: 505-511(Japanese).